Solid tumors, Hematologic malignancies
Conditions
Interventions
experience group:Blood sample collection
control group:Blood sample collection
Sponsors
West China Hospital, Sichuan University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: Patients diagnosed with hematological tumors, solid tumors (such as liver cancer, gastric cancer, etc.).
Exclusion criteria
Exclusion criteria: 1. Suffering from other malignant tumors in the past or at the same time; 2. Pregnant or breastfeeding women; 3. Patients with severe cardiovascular disease and diabetes that are difficult to control; 4. Patients with mental disorders; 5. Patients with severe infection; 6. The patient is under thrombolytic/anticoagulation therapy and has bleeding diathesis or coagulation dysfunction; or aneurysm, stroke, transient ischemic attack, arteriovenous malformation occurred in the past year; 7. Those who participated in another clinical trial within 4 weeks before the start of treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Determination of tumor burden in tumor animal models; | — |
Countries
China
Contacts
Public ContactMing Liu
Westchina Hospital, Sichuan University
Outcome results
None listed